Christopher Vitale V
Known title: President and CEOCIK: 0001463136
Associated companies
Transaction History
| AXR | ▲ Buy | Grant | 8,700 | $0 | 7/13/2026 | View on chart |
| AXR | ▲ Buy | Grant | 8,000 | $0 | 7/17/2025 | View on chart |
| AXR | ▲ Buy | Grant | 7,200 | $0 | 7/18/2024 | View on chart |
| AXR | ▲ Buy | Grant | 8,000 | $0 | 7/12/2023 | View on chart |
| AXR | ▲ Buy | Grant | 8,000 | $0 | 7/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
AMREP Target Cut to $22.44 by Consensus
Analysts have lowered their consensus price target for AMREP to $22.44, a 15.38% drop from the previous estimate. The new target sits just below the current support level of $22.77, which has been tested nine times. The change signals a shift in expectations for the company’s near‑term performance.
AMREP Target Cut to $22.44 by Consensus. Analysts have lowered their consensus price target for AMREP to $22.44, a 15.38% drop from the previous estimate. The new target sits just below the current support level of $22.77, which has been tested nine times. The change signals a shift in expectations for the company’s near‑term performance.